KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Shares Repurchased (2016 - 2023)

Historic Shares Repurchased for Bristol Myers Squibb (BMY) over the last 13 years, with Q3 2023 value amounting to $4.0 billion.

  • Bristol Myers Squibb's Shares Repurchased rose 47061.34% to $4.0 billion in Q3 2023 from the same period last year, while for Jun 2024 it was $4.0 billion, marking a year-over-year decrease of 636.7%. This contributed to the annual value of $5.2 billion for FY2023, which is 3557.06% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Shares Repurchased of $4.0 billion as of Q3 2023, which was up 47061.34% from $905.0 million recorded in Q2 2023.
  • In the past 5 years, Bristol Myers Squibb's Shares Repurchased registered a high of $7.0 billion during Q4 2019, and its lowest value of $81.0 million during Q1 2020.
  • Its 5-year average for Shares Repurchased is $2.0 billion, with a median of $1.4 billion in 2020.
  • As far as peak fluctuations go, Bristol Myers Squibb's Shares Repurchased soared by 209135.8% in 2021, and later crashed by 9500.0% in 2023.
  • Bristol Myers Squibb's Shares Repurchased (Quarter) stood at $7.0 billion in 2019, then plummeted by 79.07% to $1.5 billion in 2020, then skyrocketed by 87.78% to $2.8 billion in 2021, then dropped by 12.18% to $2.4 billion in 2022, then skyrocketed by 65.56% to $4.0 billion in 2023.
  • Its Shares Repurchased stands at $4.0 billion for Q3 2023, versus $905.0 million for Q2 2023 and $250.0 million for Q1 2023.